Annual Drug Patent Expirations for PONVORY Ponvory is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There are five patents…
Source
This chart shows the pharmaceutical companies with the most emulsion dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most emulsion dosed drugs…
Source
Which pharmaceutical companies have the most emulsion dosed drugs? Read Post »
Annual Drug Patent Expirations for RADICAVA+ORS Radicava Ors is a drug marketed by Mitsubishi Tanabe and is included in one NDA. It is available from one supplier. There are four…
Source
New patent for Mitsubishi Tanabe drug RADICAVA ORS Read Post »
Annual Drug Patent Expirations for PEDMARK Pedmark is a drug marketed by Fennec Pharms Inc and is included in one NDA. It is available from one supplier. There are four…
Source
Annual Drug Patent Expirations for TRALEMENT Tralement is a drug marketed by Am Regent and is included in one NDA. It is available from one supplier. There is one patent…
Source
Annual Drug Patent Expirations for QINLOCK Qinlock is a drug marketed by Deciphera Pharms and is included in one NDA. It is available from one supplier. There are twenty-six patents…
Source
Annual Drug Patent Expirations for MULTRYS Multrys is a drug marketed by Am Regent and is included in one NDA. It is available from one supplier. There is one patent…
Source
This chart shows the pharmaceutical companies with patents in the most countries. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
Source
Which pharmaceutical companies have the greatest global patent coverage? Read Post »
DUAVEE (bazedoxifene acetate; estrogens, conjugated) Wyeth pharms Patent: 6,479,535 Expiration: May 6, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,…
Source
Drug Patent Expirations for the Week of May 5, 2024 Read Post »
Annual Drug Patent Expirations for FABHALTA Fabhalta is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting…
Source
Get new actionable insights and updates from BiotechBlog
